Recent Updates
Recently added Catalysts
ICAD

iCAD to Report Third Quarter 2021 Financial Results on Tuesday, November 9

Key Takeaway: NASHUA, N.H., Oct. 26, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the third quarter ended September 30, 2021, after

Full Press Release Details

NASHUA, N.H., Oct. 26, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the third quarter ended September 30, 2021, after the market close, and host a conference call at 4:30pm Eastern Time on Tuesday, November 9.
Tuesday, November 9th at 4:30pm ET
Domestic: 855-327-6837
International: 631-891-4304
Conference ID: 10016811
Webcast: https://themediaframe.com/mediaframe/webcast.html?webcastid=cp8sjumj
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Brian Ritchie, LifeSci Advisors
Last updated: Oct 26, 2021